WHO ICTRP trial
Development of Biomarkers for Diabetic Nephropathy based on Exosome Multi-Omics…
KCT0005145 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0005145 |
|---|---|
| Public title | Development of Biomarkers for Diabetic Nephropathy based on Exosome Multi-Omics Study |
| Scientific title | Development of Biomarkers for Diabetic Nephropathy based on Exosome Multi-Omics Study |
| Primary sponsor | Korea University Ansan Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Endocrine, nutritional and metabolic disease |
| Interventions | Medical Device : The patients with type 2 diabetes visit the hospital annually for 4 years (total 4 times). The subjects receive a medical history, a physical examinations and blood/urine tests, annually. Additional blood and urine samples… |
| Registration date | Jun 17, 2020 |
| Target size | 260 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: